Caroline Ford
#68,158
Most Influential Person Now
Australian scientist and gynaecological cancer researcher
Caroline Ford 's AcademicInfluence.com Rankings
Caroline Ford philosophy Degrees
Philosophy
#12699
World Rank
#17707
Historical Rank
Logic
#9623
World Rank
#12217
Historical Rank
Download Badge
Philosophy
Caroline Ford 's Degrees
- PhD Cancer Biology University of Melbourne
Why Is Caroline Ford Influential?
(Suggest an Edit or Addition)According to Wikipedia, Caroline E. Ford is an Australian scientist at the University of New South Wales and advocate for women in science. Her research aims to understand why gynaecological cancers develop, how they spread and how best to treat them, and she leads the Gynaecological Cancer Research Group at the University of New South Wales, which was established in 2010.
Caroline Ford 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sensing extracellular matrix: an update on discoidin domain receptor function. (2006) (342)
- Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma (2007) (138)
- Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. (2003) (114)
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer (2013) (99)
- The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells (2013) (82)
- The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis (2013) (71)
- Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling (2015) (64)
- The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. (2014) (62)
- The untapped potential of ascites in ovarian cancer research and treatment (2020) (60)
- Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma (2017) (58)
- Progression from Normal Breast Pathology to Breast Cancer Is Associated with Increasing Prevalence of Mouse Mammary Tumor Virus-Like Sequences in Men and Women (2004) (57)
- Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients (2012) (56)
- Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion (2015) (55)
- Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer (2016) (45)
- Mouse Mammary Tumor Virus-like RNA Transcripts and DNA Are Found in Affected Cells of Human Breast Cancer (2004) (44)
- Mouse mammary tumor like virus sequences in breast milk from healthy lactating women (2011) (36)
- Wnt signalling in gynaecological cancers: A future target for personalised medicine? (2016) (35)
- Mouse Mammary Tumor-Like Virus Is Associated with p53 Nuclear Accumulation and Progesterone Receptor Positivity but not Estrogen Positivity in Human Female Breast Cancer (2004) (33)
- Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer (2006) (33)
- An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target. (2018) (32)
- ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration (2016) (31)
- The Wnt pathway: a key network in cell signalling dysregulated by viruses (2016) (31)
- Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis (2017) (28)
- ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. (2018) (25)
- Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells (2008) (23)
- Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration (2015) (23)
- A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles. (2019) (21)
- Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (2016) (17)
- Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors (2016) (16)
- Elevated Expression of the Tumor Suppressing Protein p53 is Associated with the Presence of Mouse Mammary Tumor-Like env Gene Sequences (MMTV-like) in Human Breast Cancer (2004) (15)
- The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma (2021) (14)
- ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (2020) (13)
- The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer (2009) (12)
- Sex Bias in Cohorts Included in Sports Medicine Research (2021) (10)
- Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight (2019) (10)
- Mouse Mammary Tumor-Like Virus Is Associated with p 53 Nuclear Accumulation and Progesterone Receptor Positivity but not Estrogen Positivity in Human Female Breast Cancer (2004) (8)
- Targeting the ROR 1 and ROR 2 receptors in epithelial ovarian cancer inhibits cell migration and invasion (2015) (7)
- ROR2 Is Epigenetically Regulated in Endometrial Cancer (2021) (5)
- Total and endothelial cell-derived cell-free DNA in blood plasma does not change during menstruation (2021) (5)
- I-AbACUS: a Reliable Software Tool for the Semi-Automatic Analysis of Invasion and Migration Transwell Assays (2018) (4)
- Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer. (2021) (4)
- An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles. (2021) (4)
- Correspondence re: C. Ford, et al. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin. Cancer Res., 9: 1118-1120, 2003. (2004) (4)
- Selective modulation of Wnt-binding receptor tyrosine kinase ROR2 expression by human cytomegalovirus regulates trophoblast migration. (2019) (3)
- Retraction for Ford et al., Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells (2010) (3)
- Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology (2022) (3)
- Target sequence heterogeneity causes the 'hook effect' in fluorescent dye-based quantitative PCR. (2020) (3)
- Virtual patient consultations and the use of an ePortfolio assessment to support student learning of integrated professional skills (2016) (3)
- ROR1 and ROR2 expression in pancreatic cancer (2021) (2)
- Comment on: Wnt5a inhibited human trophoblast cell line HTR8/SVneo invasion: implications for early placentation and preeclampsia (2017) (2)
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer (2013) (2)
- The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells (2022) (2)
- Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents (2021) (2)
- Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2022) (1)
- Abstract 1636: The role of the ROR receptors in ovarian cancer progression and chemoresistance (2016) (1)
- Retracted Manuscript: The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer (2011) (1)
- Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival (2022) (1)
- Comparison of total and endometrial circulating cell-free DNA in women with and without endometriosis. (2021) (1)
- Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (2016) (0)
- Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance (2020) (0)
- Abstract 2942: ROR1: A novel target in endometrial cancer (2020) (0)
- Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (2022) (0)
- Recovery Efficiency of Cell-Free DNA After Bisulfite Conversion. (2022) (0)
- Abstract 731: Deciphering the origin of circulating cell-free DNA and its alterations during menstruation (2020) (0)
- Abstract 106: Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer (2018) (0)
- The untapped potential of ascites in ovarian cancer research and treatment (2020) (0)
- Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy (2021) (0)
- Endogenous cell-free DNA in fetal bovine serum introduces artifacts to in vitro cell-free DNA models. (2022) (0)
- Ror2 is a novel target of the Wnt signaling pathway involved in metastasis and chemotherapy resistance (2015) (0)
- Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer (2021) (0)
- Abstract B28: Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer (2020) (0)
- ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration (2016) (0)
- Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma (2017) (0)
- I-AbACUS: a Reliable Software Tool for the Semi-Automatic Analysis of Invasion and Migration Transwell Assays (2018) (0)
- Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form (2022) (0)
- Abstract 333: SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer. (2012) (0)
- BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER (2022) (0)
- Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer (2022) (0)
- Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody (2021) (0)
- 43 Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5 (2010) (0)
- Hear the Ror! the Role of Wnt Signalling in Ovarian Cancer (2014) (0)
- Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis. (2022) (0)
This paper list is powered by the following services:
Other Resources About Caroline Ford
What Schools Are Affiliated With Caroline Ford ?
Caroline Ford is affiliated with the following schools:
